The purpose of this system is to help connect interested study participants with clinical
research centers. The following is a brief outline explaining the main steps involved in
using this system. Please note that every step in this process is optional.
| 1. |
Select a clinical trial that you feel best suits your (or the participant's) health condition. |
| 2. |
Answer the screening questions to see if you (or the participant) meet the preliminary qualifications for the study. The answers to these questions
are not retained by this system. |
| 3. |
Select a study center to contact for additional information about the clinical trial. |
| 4. |
Set up an account and agree to the terms of use for this system. |
| 5. |
Submit your information to the study center you selected. |
| 6. |
The study center may contact you and may ask more questions about your (or the participant's) eligibility for the study. The study center may invite you
(and the participant if applicable) to travel to the study center for additional screening tests. Novartis cannot guarantee that you
will be contacted by the study center. |
| 7. |
If you are eligible to participate in the study, then you will be required to sign an
informed consent before enrolling in the study. An informed consent is provided to you to help you understand the clinical trial, the nature of
the medical treatment (if any), procedures and known risks involved, before you agree to participate in the study.
|
